BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21628041)

  • 1. Palliative care in the management of advanced HIV/AIDS.
    Fausto JA; Selwyn PA
    Prim Care; 2011 Jun; 38(2):311-26, ix. PubMed ID: 21628041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
    Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical care of immunocompromised patients: human immunodeficiency virus.
    Rosen MJ; Narasimhan M
    Crit Care Med; 2006 Sep; 34(9 Suppl):S245-50. PubMed ID: 16917430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic approaches to AIDS-related malignancies.
    Berretta M; Cinelli R; Martellotta F; Spina M; Vaccher E; Tirelli U
    Oncogene; 2003 Sep; 22(42):6646-59. PubMed ID: 14528290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
    J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome. 565 autopsies in adults with the acquired immunodeficiency syndrome, Los Angeles, Calif, 1982-1993 [corrected].
    Klatt EC; Nichols L; Noguchi TT
    Arch Pathol Lab Med; 1994 Sep; 118(9):884-90. PubMed ID: 8080357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative Care in the Management of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in the Primary Care Setting.
    Mitchell LR; Shah N; Selwyn PA
    Prim Care; 2019 Sep; 46(3):433-445. PubMed ID: 31375191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
    Gandhi T; Wei W; Amin K; Kazanjian P
    Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence variation in malignancies associated or not with AIDS at an outpatient care center, 1997-2005].
    Laurido M; Urueña A; Vizzotti C; Bugarin G; Cassetti I
    Medicina (B Aires); 2007; 67(3):243-6. PubMed ID: 17628911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of combined antiretroviral therapy on multiple AIDS-defining illnesses in an HIV seroconverter cohort].
    Ferreros I; Hurtado I; del Amo J; Muga R; del Romero J; García P; Alastrué I; Belda J; Guevara M; Pérez S;
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):179-84. PubMed ID: 21333403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
    Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
    AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vietnam: integrating palliative care into HIV/AIDS and cancer care.
    Krakauer EL; Ngoc NT; Green K; Van Kham L; Khue LN
    J Pain Symptom Manage; 2007 May; 33(5):578-83. PubMed ID: 17482051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human immunodeficiency virus and AIDS-associated immune reconstitution syndrome. State of the art].
    Reyes-Corcho A; Bouza-Jiménez Y
    Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):110-21. PubMed ID: 19632745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous clues to HIV infection: diagnosis and treatment.
    Cockerell CJ
    Semin Dermatol; 1994 Dec; 13(4):275-85. PubMed ID: 7848822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.
    Gaitan Cepeda LA; Ceballos Salobreña A; López Ortega K; Arzate Mora N; Jiménez Soriano Y
    Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E85-93. PubMed ID: 18223535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.
    Podlasin RB; Wiercinska-Drapalo A; Olczak A; Beniowski M; Smiatacz T; Malolepsza E; Juszczyk J; Leszczyszyn-Pynka M; Mach T; Mian M; Knysz B; Horban A
    Infection; 2006 Aug; 34(4):196-200. PubMed ID: 16896577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.